Literature DB >> 17114944

Gene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAs.

Markus Hossbach1, Jens Gruber, Mary Osborn, Klaus Weber, Thomas Tuschl.   

Abstract

Synthetic small interfering RNA (siRNA) duplexes are widely used to transiently and sequence-specifically disrupt gene expression in mammalian cultured cells. The efficiency and specificity of mRNA cleavage is partly affected by the presence of the nontargeting "passenger" or "sense" siRNA strand, which is required for presentation of the target-complementary or guide siRNA strand to the double-strand-specific RNA silencing protein machinery. We show that siRNA duplexes can be designed that are solely composed of two fully target-complementary guide strands that are sufficiently complementary to each other to form stable duplexes with characteristic 3' overhanging ends. The general feasibility of this approach is documented by transient knockdown of lamin A/C and emerin in HeLa cells. The silencing efficiencies of guide-only siRNA duplexes are comparable to prototypical fully paired passenger/guide duplex siRNAs, even though guide-only siRNA duplexes may contain a significant number of nonWatson-Crick and G/U wobble base pairs. Such siRNA duplexes may offer advantages regarding production costs and specificity of gene silencing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114944     DOI: 10.4161/rna.3.2.3110

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  8 in total

1.  Dual-targeting siRNAs.

Authors:  Katrin Tiemann; Britta Höhn; Ali Ehsani; Stephen J Forman; John J Rossi; Pål Saetrom
Journal:  RNA       Date:  2010-04-21       Impact factor: 4.942

2.  Potent and systematic RNAi mediated silencing with single oligonucleotide compounds.

Authors:  Jennifer Lapierre; William Salomon; James Cardia; Karen Bulock; Jessica T Lam; William J Stanney; Glenna Ford; Bernice Smith-Anzures; Tod Woolf; Joanne Kamens; Anastasia Khvorova; Dmitry Samarsky
Journal:  RNA       Date:  2011-04-14       Impact factor: 4.942

3.  Long double-stranded multiplex siRNAs for dual genes silencing.

Authors:  Wei Peng; Jianxin Chen; Yinchao Qin; Zhenjun Yang; York Yuanyuan Zhu
Journal:  Nucleic Acid Ther       Date:  2013-05-08       Impact factor: 5.486

Review 4.  Sequence-non-specific effects of RNA interference triggers and microRNA regulators.

Authors:  Marta Olejniczak; Paulina Galka; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

5.  Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs.

Authors:  Narendra Vaish; Feng Chen; Shaguna Seth; Kathy Fosnaugh; Yan Liu; Roger Adami; Tod Brown; Yan Chen; Pierrot Harvie; Rachel Johns; Gregory Severson; Brian Granger; Patrick Charmley; Michael Houston; Michael V Templin; Barry Polisky
Journal:  Nucleic Acids Res       Date:  2010-11-02       Impact factor: 16.971

6.  Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression.

Authors:  Xu-Dong Xu; Han-Bin Shen; Li Zhu; Jian-Qin Lu; Lin Zhang; Zhi-Yong Luo; Ya-Qun Wu
Journal:  Onco Targets Ther       Date:  2017-03-23       Impact factor: 4.147

7.  Design of siRNA Therapeutics from the Molecular Scale.

Authors:  Phillip Angart; Daniel Vocelle; Christina Chan; S Patrick Walton
Journal:  Pharmaceuticals (Basel)       Date:  2013

8.  Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.

Authors:  Agnieszka Fiszer; Marta Olejniczak; Paulina Galka-Marciniak; Agnieszka Mykowska; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2013-09-13       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.